Vertex Pharmaceuticals Incorporated
US ˙ NasdaqGS ˙ US92532F1003

SecurityVRTX / Vertex Pharmaceuticals Incorporated
InstitutionCaptrust Financial Advisors
Latest Disclosed Ownership32,092 shares
Latest Disclosed Value $ 14,330,486
Captrust Financial Advisors reports 132.48% increase in ownership of VRTX / Vertex Pharmaceuticals Incorporated

On May 14, 2026 - Captrust Financial Advisors filed a 13F-HR form disclosing ownership of 32,092 shares of Vertex Pharmaceuticals Incorporated (US:VRTX) valued at $14,330,362 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 13,804 shares of Vertex Pharmaceuticals Incorporated. This represents a change in shares of 132.48% during the quarter. The current value of the position is $13,746,287 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 32,092 18,288 132.48 14,330 128.99 0.0247
2026-02-17 2025-12-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 13,804 1,730 14.33 6,258 32.36 0.0119
2025-11-19 2025-09-30 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 12,074 -1,238 -9.30 4,728 -20.22 0.0096
2025-08-15 2025-06-30 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 13,312 -218 -1.61 5,926 -9.65 0.0132
2025-05-15 2025-03-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 13,530 1,482 12.30 6,560 35.21 0.0165
2025-02-14 2024-12-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 12,048 -2,361 -16.39 4,852 -27.61 0.0139
2024-11-14 2024-09-30 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 14,409 307 2.18 6,701 1.39 0.0199
2024-08-15 2024-06-30 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 14,102 -2,546 -15.29 6,610 -5.02 0.0213
2024-05-15 2024-03-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 16,648 -5,461 -24.70 6,959 -22.65 0.0256
2024-02-14 2023-12-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 22,109 3,245 17.20 8,996 37.14 0.0310
2023-11-15 2023-09-30 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 18,864 -2,210 -10.49 6,560 -11.56 0.0251
2023-08-15 2023-06-30 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 21,074 528 2.57 7,416 14.57 0.0292
2023-05-15 2023-03-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 20,546 1,052 5.40 6,473 14.99 0.0284
2023-02-15 2022-12-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 19,494 -26 -0.13 5,629 -0.41 0.0283
2022-11-16 2022-09-30 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 19,520 -930 -4.55 5,652 -1.93 0.0329
2022-08-23 2022-06-30 13F/A-1 VERTEX PHARMACEUTICALS INC COM Common Stock 92532F100 20,450 1,012 5.21 5,763 13.60 0.0372
2022-08-16 2022-06-30 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 25,296 5,858 7,117 0.0516
2022-05-16 2022-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 19,438 2,752 16.49 5,073 38.46 0.0328
2022-02-14 2021-12-31 13F VERTEX PHARMACEUTICALS INC COM Common Stock 92532F100 16,686 -2,612 -13.54 3,664 4.69 0.0251
2021-11-16 2021-09-30 13F VERTEX PHARMACEUTICALS INC COM Common Stock 92532F100 19,298 3,685 23.60 3,500 11.18 0.0291
2021-08-16 2021-06-30 13F VERTEX PHARMACEUTICALS INC COM Common Stock 92532F100 15,613 10,833 226.63 3,148 206.52 0.0293
2021-05-17 2021-03-31 13F VERTEX PHARMACEUTICALS INC COM Common Stock 92532F100 4,780 3,107 185.71 1,027 160.00 0.0111
2021-02-16 2020-12-31 13F VERTEX PHARMACEUTICALS INC COM Common Stock 92532F100 1,673 -2,938 -63.72 395 -68.68 0.0052
2020-11-17 2020-09-30 13F VERTEX PHARMACEUTICALS INC COM Common Stock 92532F100 4,611 647 16.32 1,261 11.10 0.0209
2020-08-14 2020-06-30 13F VERTEX PHARMACEUTICALS INC COM Common Stock 92532F100 3,964 2,248 131.00 1,135 193.28 0.0187
2020-05-15 2020-03-31 13F VERTEX PHARMACEUTICALS INC COM Common Stock 92532F100 1,716 752 78.01 387 82.55 0.0085
2020-02-14 2019-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 964 736 322.81 212 443.59 0.0033
2019-11-14 2019-09-30 13F VERTEX PHARMACEUTICALS INC COM Common Stock 92532F100 228 6 2.70 39 -4.88 0.0014
2019-08-13 2019-06-30 13F VERTEX PHARMACEUTICALS INC COM Common Stock 92532F100 222 149 204.11 41 215.38 0.0015
2019-05-15 2019-03-31 13F VERTEX PHARMACEUTICALS INC COM Common Stock 92532F100 73 -21 -22.34 13 -18.75 0.0005
2019-02-13 2018-12-31 13F VERTEX PHARMACEUTICALS INC COM Common Stock 92532F100 94 -19 -16.81 16 -27.27 0.0009
2018-11-15 2018-09-30 13F VERTEX PHARMACEUTICALS INC COM Common Stock 92532F100 113 8 7.62 22 22.22 0.0010
2018-08-13 2018-06-30 13F VERTEX PHARMACEUTICALS INC COM Common Stock 92532F100 105 52 98.11 18 125.00 0.0010
2018-05-15 2018-03-31 13F VERTEX PHARMACEUTICALS INC COM Common Stock 92532F100 53 -2 -3.64 8 0.00 0.0005
2018-02-14 2017-12-31 13F VERTEX PHARMACEUTICALS INC COM Common Stock 92532F100 55 18 48.65 8 33.33 0.0005
2018-02-16 2017-09-30 13F/A-1 VERTEX PHARMACEUTICALS INC COM Common Stock 92532F100 37 -195 -84.05 6 -80.00 0.0005
2017-08-10 2017-06-30 13F VERTEX PHARMACEUTICALS INC COM Common Stock 92532F100 232 232 30 0.0026
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.